<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 27.2: Advanced Autoimmunity & Neuro-Immunology</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - PURPLE theme for Neuro-Immunology */
        .module-header {
            background: linear-gradient(135deg, #4c1d95 0%, #7c3aed 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #7c3aed;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #7c3aed;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #7c3aed;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f5f3ff;
            border: 2px solid #7c3aed;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #4c1d95;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #4c1d95;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #6d28d9;
            margin: 30px 0 15px 0;
        }

        /* Paragraphs & Text */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #e9d5ff 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #4c1d95 0%, #7c3aed 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
            letter-spacing: 0.5px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #7c3aed, #4c1d95);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            color: white;
            flex-shrink: 0;
        }

        /* Statistics Box */
        .stats-box {
            background: linear-gradient(135deg, #4c1d95 0%, #7c3aed 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            position: relative;
            z-index: 1;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            color: white;
            line-height: 1;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 13px;
            color: rgba(255, 255, 255, 0.85);
            text-transform: uppercase;
            letter-spacing: 1px;
        }

        /* Data Table */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e5e5;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background: #f3f4f6;
            padding: 15px;
            font-weight: 600;
            color: #4c1d95;
            border-bottom: 2px solid #e5e5e5;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #eee;
            color: #444;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Check Understanding */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #7c3aed;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            font-family: inherit;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f5f3ff;
            border-radius: 8px;
            color: #4c1d95;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f3f4f6;
            padding: 25px;
            border-radius: 12px;
            margin-top: 40px;
        }

        .references-box {
            margin-top: 40px;
            padding-top: 25px;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .references-box h4 {
            color: #333;
            margin-bottom: 15px;
        }

        .references-box ul {
            list-style: none;
            padding: 0;
        }

        .references-box li {
            margin-bottom: 10px;
            line-height: 1.5;
        }

        .footer-logo {
            max-width: 140px;
            opacity: 0.8;
            margin-top: 20px;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
            margin-top: 60px;
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 27: Specialty Applications</p>
            <h1 class="lesson-title">Lesson 2: Advanced Autoimmunity & Neuro-Immunology</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Expert Level</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#molecular-mimicry"><span class="section-num">1</span>Molecular Mimicry & Occult Triggers</a></li>
                <li><a href="#t-cell-paradigm"><span class="section-num">2</span>The Th1/Th2/Th17/Treg Paradigm</a></li>
                <li><a href="#neuro-immunology"><span class="section-num">3</span>Neuro-Immunology: The BBB & Glia</a></li>
                <li><a href="#data-decisions"><span class="section-num">4</span>Advanced Lymphocyte Mapping</a></li>
                <li><a href="#genetic-aip"><span class="section-num">5</span>HLA-Typing & Personalized Nutrition</a></li>
                <li><a href="#advanced-therapeutics"><span class="section-num">6</span>LDN & Peptide Interventions</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Master the identification of occult infections and cross-reactive proteins via Root Cause Analysis.</li>
                <li>Understand the immunometabolic polarization of T-cell subsets and their modulation.</li>
                <li>Evaluate the integrity of the Blood-Brain Barrier (BBB) in neuro-autoimmune presentations.</li>
                <li>Interpret advanced cytokine panels and lymphocyte maps for precision protocol design.</li>
                <li>Implement Low Dose Naltrexone (LDN) and immunomodulatory peptides in clinical practice.</li>
            </ul>
        </div>

        <h2 id="molecular-mimicry">1. Molecular Mimicry: The "R" in Root Cause Analysis</h2>
        <p>In the <span class="highlight">B.R.I.D.G.E. Methodâ„¢</span>, the "R" (Root Cause Analysis) is paramount for autoimmune cases. While conventional rheumatology focuses on symptom suppression via biologics, the integrative practitioner investigates <strong>molecular mimicry</strong>â€”a process where the immune system misidentifies foreign antigens as self-tissue due to structural similarities.</p>

        <p>A classic example is the relationship between <em>Klebsiella pneumoniae</em> and Ankylosing Spondylitis (AS). The nitrogenase enzyme in <em>Klebsiella</em> shares a high degree of homology with the HLA-B27 molecule. When the immune system mounts a defense against a gut overgrowth of <em>Klebsiella</em>, it may inadvertently begin attacking the spinal ligaments and joints.</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">90%</div>
                    <div class="stat-label">HLA-B27 Positivity in AS</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">32%</div>
                    <div class="stat-label">Gluten Cross-Reactivity</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">4.2x</div>
                    <div class="stat-label">EBV Risk Factor for MS</div>
                </div>
            </div>
        </div>

        <h3>Occult Infections & Food Cross-Reactivity</h3>
        <p>Beyond bacteria, viral triggers like <span class="highlight">Epstein-Barr Virus (EBV)</span> and <em>Cytomegalovirus</em> (CMV) act as chronic "mediators" (as per the ATM framework). Furthermore, food proteins can mimic human tissue. For instance, the protein sequences in <strong>dairy (casein)</strong> can cross-react with myelin basic protein in some Multiple Sclerosis (MS) patients, while <strong>gliadin</strong> (gluten) can mimic cerebellar tissue, leading to gluten ataxia.</p>

        <h2 id="t-cell-paradigm">2. The Th1/Th2/Th17/Treg Paradigm</h2>
        <p>The immune system is not a binary "on/off" switch; it is a complex balance of specialized T-cell lineages. Understanding these subsets allows the practitioner to use the "B" (Blend Approaches) of the B.R.I.D.G.E. framework to apply targeted nutraceuticals.</p>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>T-Cell Subset</th>
                        <th>Primary Function</th>
                        <th>Associated Condition</th>
                        <th>Nutraceutical Modulator</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Th1</strong></td>
                        <td>Intracellular pathogens</td>
                        <td>Hashimoto's, Type 1 Diabetes</td>
                        <td>Berberine, Ginger</td>
                    </tr>
                    <tr>
                        <td><strong>Th2</strong></td>
                        <td>Extracellular parasites/allergens</td>
                        <td>Asthma, Eczema, Lupus (SLE)</td>
                        <td>Quercetin, Perilla Oil</td>
                    </tr>
                    <tr>
                        <td><strong>Th17</strong></td>
                        <td>Tissue destruction/Inflammation</td>
                        <td>RA, Psoriasis, IBD, MS</td>
                        <td>Curcumin, Boswellia, Sulforaphane</td>
                    </tr>
                    <tr>
                        <td><strong>Treg</strong></td>
                        <td>Immune tolerance (Peacekeepers)</td>
                        <td>Deficiency leads to Autoimmunity</td>
                        <td>Vitamin D, Butyrate, TGF-Î²</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <p>The <span class="highlight">Th17/Treg ratio</span> is often the most critical biomarker for disease progression. Th17 cells produce IL-17, a potent pro-inflammatory cytokine that drives neutrophil recruitment and tissue damage. Conversely, Tregs (Regulatory T-cells) produce IL-10 and TGF-Î² to dampen the response. Chronic stress (elevated cortisol) and Vitamin D deficiency are the two primary drivers of Treg depletion.</p>

        <h2 id="neuro-immunology">3. Neuro-Immunology: The BBB & Glial Activation</h2>
        <p>Neuro-immunology represents the intersection of the nervous and immune systems. A breakthrough in this field is the discovery of the <span class="highlight">glymphatic system</span> and the realization that the brain is not "immuno-privileged" but "immuno-distinct."</p>
        
        <p>In conditions like "Brain Fog," PANS/PANDAS, and early-stage neurodegeneration, the <strong>Blood-Brain Barrier (BBB)</strong> becomes permeable (often termed "Leaky Brain"). This allows systemic cytokines and antibodies to enter the central nervous system, activating <strong>microglia</strong>â€”the brain's resident immune cells. Once microglial cells are "primed," they remain in a hyper-excitable state, releasing neurotoxic quinolinic acid and glutamate, leading to neuronal death.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ§ </div>
                <div>
                    <p class="box-label">Case Study: Neuro-Autoimmune Convergence</p>
                    <p style="color: rgba(255,255,255,0.8); margin:0; font-size:12px;">Refractory Brain Fog and Motor Tics</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">EM</div>
                    <div class="patient-info">
                        <h4>Elena M., 34</h4>
                        <p>Diagnosis: Hashimoto's Thyroiditis with Neurological Symptoms</p>
                    </div>
                </div>
                <p><strong>Presenting Symptoms:</strong> Severe cognitive dysfunction, transient motor tics, and anxiety. Conventional labs showed "optimal" TSH (1.8 uIU/mL) on Levothyroxine, but TPO antibodies remained >900 IU/mL.</p>
                <p><strong>Intervention:</strong> Using the B.R.I.D.G.E. Methodâ„¢, we identified a latent <em>Streptococcus</em> infection (Root Cause) and used Cyrex Array 20 to confirm BBB permeability. We initiated a protocol of high-dose Resveratrol (to dampen microglia) and Low Dose Naltrexone (LDN) at 3.0mg.</p>
                <p><strong>Outcomes:</strong> After 4 months, TPO antibodies dropped to 140 IU/mL; motor tics resolved entirely, and cognitive testing showed a 40% improvement in processing speed.</p>
            </div>
        </div>

        <h2 id="data-decisions">4. Data-Driven Decisions: Interpreting Lymphocyte Maps</h2>
        <p>Standard CBC with differential is insufficient for advanced autoimmune management. The integrative practitioner utilizes <strong>Lymphocyte Immunophenotyping</strong>. This test uses flow cytometry to count specific cell surface markers (CD markers).</p>

        <ul>
            <li><strong>CD4/CD8 Ratio:</strong> A high ratio (>2.5) often indicates Th1 dominance or acute autoimmune flare, while a low ratio (<1.0) may suggest chronic viral load or immune exhaustion.</li>
            <li><strong>Natural Killer (NK) Cell Activity (CD56/CD16):</strong> Low NK cell activity is a hallmark of chronic fatigue syndrome and may allow occult infections to persist.</li>
            <li><strong>Cytokine Panels:</strong> Measuring serum IL-6, TNF-Î±, and IL-17 provides a real-time "weather report" of systemic inflammation, guiding the dosage of anti-inflammatory botanicals.</li>
        </ul>

        <h2 id="genetic-aip">5. Individualizing AIP Based on HLA-Typing</h2>
        <p>The Autoimmune Paleo (AIP) protocol is a powerful tool, but it is not a one-size-fits-all solution. In the "I" (Individualize Care) phase of our methodology, we look at <strong>HLA-DQ and HLA-DR genetics</strong>.</p>
        
        <p>Specific HLA genotypes are highly correlated with certain sensitivities:</p>
        <ol>
            <li><strong>HLA-DQ2/DQ8:</strong> High risk for Celiac and non-celiac gluten sensitivity. For these individuals, even "certified gluten-free" grains like oats may trigger an immune response due to avenin cross-reactivity.</li>
            <li><strong>HLA-DRB1:</strong> Associated with Rheumatoid Arthritis and mold sensitivity (CIRS). These clients may need to prioritize a low-mycotoxin diet over standard AIP.</li>
            <li><strong>HLA-B27:</strong> As discussed, requires strict avoidance of starch to starve <em>Klebsiella</em> populations in the gut.</li>
        </ol>

        <h2 id="advanced-therapeutics">6. Clinical Application: LDN & Peptide Therapies</h2>
        <p>When lifestyle and nutrition reach a plateau (the "Evolve & Optimize" stage), we look to advanced immunomodulators. <strong>Low Dose Naltrexone (LDN)</strong> is a cornerstone of integrative autoimmunity. Unlike the standard 50mg dose used for addiction, the 1.5mgâ€“4.5mg dose acts as a "hormetic" stressor.</p>

        <p><strong>LDN Mechanism:</strong> It briefly blocks opioid receptors, causing the body to compensate by increasing the production of endogenous endorphins and upregulating the number of opioid receptors. These endorphins then bind to receptors on T-cells, shifting the immune system away from a Th17/pro-inflammatory state toward a Treg/regulatory state.</p>

        <h3>Immunomodulatory Peptides</h3>
        <p>Peptides are short chains of amino acids that act as signaling molecules. In refractory cases, two peptides are particularly noteworthy:</p>
        <ul>
            <li><strong>Thymosin Alpha-1 (TÎ±1):</strong> Naturally produced by the thymus, it restores immune balance, enhances NK cell activity, and has been used effectively in chronic viral-triggered autoimmunity.</li>
            <li><strong>BPC-157:</strong> Known for "Body Protective Compound," it is essential for repairing the "leaky gut" and "leaky brain" barriers that allow triggers to enter systemic circulation.</li>
        </ul>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <p class="question-text">1. Why might a patient with Ankylosing Spondylitis fail to improve on a standard "healthy" diet that includes complex carbohydrates like sweet potatoes and brown rice?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Patients with the HLA-B27 genotype often have a cross-reactivity with Klebsiella bacteria. Klebsiella feeds on dietary starches. A high-starch diet can fuel Klebsiella overgrowth, worsening the molecular mimicry-driven attack on joint tissues. A low-starch approach is often required.</div>
            </div>

            <div class="question-item">
                <p class="question-text">2. What is the primary mechanism by which Low Dose Naltrexone (LDN) modulates the immune system?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">LDN causes a transient blockade of opioid receptors, leading to a "rebound" increase in endogenous endorphins (met-enkephalin). These endorphins act on Opioid Growth Factor Receptors (OGFr) on immune cells to promote Treg production and suppress Th17-mediated inflammation.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Root Causes:</strong> Always investigate occult infections (EBV, Klebsiella) and food cross-reactivity (Casein, Gliadin) in autoimmune cases.</li>
                <li><strong>Immune Balance:</strong> Focus on the Th17/Treg ratio; use Vitamin D, Butyrate, and Sulforaphane to support regulatory T-cell function.</li>
                <li><strong>Neuro-Barrier Integrity:</strong> "Leaky Brain" (BBB permeability) is a primary driver of neurological symptoms in systemic autoimmunity.</li>
                <li><strong>Precision Tools:</strong> Use HLA-typing to individualize dietary protocols and consider LDN or peptides like TÎ±1 for refractory cases.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Vojdani, A., et al. (2021). "Molecular Mimicry as a Mechanism of Autoimmune Disease." <em>Clinical Reviews in Allergy & Immunology.</em></li>
                <li>El-Hage, N., et al. (2023). "The Role of Microglia in Neuro-Immunology: From Health to Disease." <em>Journal of Neuroinflammation.</em></li>
                <li>Younger, J., et al. (2014). "Low-dose naltrexone for the treatment of fibromyalgic pain: A small-randomized outcomes study." <em>Biomedicines.</em></li>
                <li>Rashid, T., & Ebringer, A. (2012). "Ankylosing spondylitis is linked to Klebsiella - the evidence." <em>Clinical Rheumatology.</em></li>
                <li>Cusick, M. F., et al. (2012). "Molecular Mimicry as a Mechanism of Autoimmune Disease." <em>Clinical Reviews in Allergy & Immunology.</em></li>
                <li>Shoenfeld, Y., et al. (2015). "The Mosaic of Autoimmunity: The Factors Associated with Autoimmune Disease." <em>Elsevier Science.</em></li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Integrative Medicine Practitioner Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All rights reserved. Confidential Professional Coursework.</p>
        </footer>
    </div>
</body>

</html>